(Q43786539)

English

HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels (English)

1 reference

Europe PubMed Central

26 November 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

26 November 2017

author name string

Martínez-González J

1

1 reference

Europe PubMed Central

26 November 2017

Alfón J

2

1 reference

Europe PubMed Central

26 November 2017

Berrozpe M

3

1 reference

Europe PubMed Central

26 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

26 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

26 November 2017

159

1 reference

Europe PubMed Central

26 November 2017

1

1 reference

Europe PubMed Central

26 November 2017

27-33

1 reference

Europe PubMed Central

26 November 2017

Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway: implication for in vivo interventions in the porcine model

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Esterified Cholesterol Accumulation Induced by Aggregated LDL Uptake in Human Vascular Smooth Muscle Cells Is Reduced by HMG-CoA Reductase Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Low-density lipoprotein-independent effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Cloning and characterization of inducible nitric oxide synthase from mouse macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Superoxide and peroxynitrite in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Platelet Deposition on Eroded Vessel Walls at a Stenotic Shear Rate Is Inhibited by Lipid-Lowering Treatment With Atorvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Improved nonradioactive RT-PCR method for relative quantification of mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900469-5

7 January 2021

Identifiers

10.1016/S0021-9150(01)00469-5

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43786539&oldid=2103324118"